ALPS Advisors’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

ALPS Advisors’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-27,366	Closed	-$319K	–	1104
2022 Q1	$319K	Sell	27,366 -2,910	-10%	-$34.6K	﹤0.01%	748
2021 Q4	$553K	Buy	+30,276	New	+$384K	0.01%	481
2020 Q4	–	Sell	-32,842	Closed	-$693K	–	891
2020 Q3	$693K	Sell	32,842 -1,422	-4%	-$33.2K	0.01%	388
2020 Q2	$990K	Sell	34,264 -4,568	-12%	-$138K	0.01%	314
2020 Q1	$1.36M	Sell	38,832 -4,534	-10%	-$147K	0.02%	243
2019 Q4	$1.06M	Buy	+43,366	New	+$761K	0.01%	334

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

ALPS Advisors's OYST Position: Q2 2022 in Review

ALPS Advisors sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q2 2022, closing a stake of 27,366 shares — an estimated $319K sold.

ALPS Advisors first reported a position in OYST in Q4 2019 and held it in 6 quarters. The position peaked at $1.36M in Q1 2020. 61 funds tracked by Wall St. Rank hold OYST as of Q2 2022.

ALPS Advisors reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
ALPS Advisors sold 27,366 Oyster Point Pharma, Inc. Common Stock shares in Q2 2022, an estimated $319K.
ALPS Advisors first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
ALPS Advisors's Oyster Point Pharma, Inc. Common Stock position peaked at $1.36M in Q1 2020.
61 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q2 2022.

Based on ALPS Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.